BIO Key Company Top Insiders
BKYI Stock | USD 1.59 0.05 3.05% |
BIO Key's insiders are aggressively buying. The analysis of insider sentiment suggests that almost all BIO Key International insiders are, at present, extremely bullish. BIO Key employs about 51 people. The company is managed by 20 executives with a total tenure of roughly 170 years, averaging almost 8.0 years of service per executive, having 2.55 employees per reported executive.
Kwok Wong Chairman MD ViceChairman |
Michael DePasquale Chairman Chairman, CEO and Pres |
BIO Key's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
2023-11-30 | James David Sullivan | Acquired 1111 @ 3.06 | View | ||
2023-11-27 | James David Sullivan | Acquired 555 @ 2.88 | View | ||
2023-11-24 | James David Sullivan | Acquired 1648 @ 2.88 | View | ||
2023-10-30 | Michael W Depasquale | Acquired 9166 @ 3.06 | View |
Monitoring BIO Key's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
BIO |
BIO Key Management Team Effectiveness
The company has return on total asset (ROA) of (0.273) % which means that it has lost $0.273 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2593) %, meaning that it created substantial loss on money invested by shareholders. BIO Key's management efficiency ratios could be used to measure how well BIO Key manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1. The BIO Key's current Return On Capital Employed is estimated to increase to -1.46. As of now, BIO Key's Net Tangible Assets are increasing as compared to previous years. The BIO Key's current Intangibles To Total Assets is estimated to increase to 0.17, while Total Assets are projected to decrease to under 10.2 M.The current Common Stock Shares Outstanding is estimated to decrease to about 382.6 K. The current Net Loss is estimated to decrease to about (4.8 M)
BIO Key Workforce Comparison
BIO Key International is number one stock in number of employees category among related companies. The total workforce of Information Technology industry is currently estimated at about 34,447. BIO Key adds roughly 51.0 in number of employees claiming only tiny portion of equities under Information Technology industry.
The company has Profit Margin (PM) of (1.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.42) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.42. BIO Key Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIO Key insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIO Key's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BIO Key insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Yao Jianhui over two months ago BIO Key exotic insider transaction detected | ||
James Sullivan over three months ago Acquisition by James Sullivan of 1 shares of BIO Key subject to Rule 16b-3 | ||
James Sullivan over three months ago Purchase by James Sullivan of 20000 shares of BIO Key | ||
James Sullivan over three months ago Purchase by James Sullivan of 10000 shares of BIO Key | ||
James Sullivan over three months ago Purchase by James Sullivan of 228000 shares of BIO Key | ||
James Sullivan over six months ago Purchase by James Sullivan of tradable shares of BIO Key | ||
James Sullivan over six months ago Purchase by James Sullivan of 1200 shares of BIO Key | ||
James Sullivan over six months ago Purchase by James Sullivan of 5000 shares of BIO Key |
BIO Key Notable Stakeholders
A BIO Key stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BIO Key often face trade-offs trying to please all of them. BIO Key's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BIO Key's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kwok Wong | MD ViceChairman | Profile | |
Michael DePasquale | Chairman, CEO and Pres | Profile | |
Mark Cochran | President PortalGuard | Profile | |
Pieter Knook | Director | Profile | |
Thomas Gilley | Director | Profile | |
Jianhui Yau | Director | Profile | |
Thomas Bush | Director | Profile | |
Fabian Shin | Director | Profile | |
Robert Michel | Director | Profile | |
Charles Romeo | Independent Director | Profile | |
John Schoenherr | Independent Director | Profile | |
Barbara Rivera | Director | Profile | |
Scott Mahnken | VP of Marketing | Profile | |
Renat Zhdanov | Chief Scientist and VP | Profile | |
Cecilia Welch | Chief Officer | Profile | |
Akintunde Jeje | Managing Africa | Profile | |
Alex Rocha | Managing EMEA | Profile | |
Frederick Corsentino | Chief Revenue Officer | Profile | |
James Sullivan | Senior Officer | Profile | |
Mira LaCous | Chief Officer | Profile |
About BIO Key Management Performance
The success or failure of an entity such as BIO Key International often depends on how effective the management is. BIO Key management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BIO management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BIO management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.96) | (1.00) | |
Return On Capital Employed | (1.53) | (1.46) | |
Return On Assets | (0.81) | (0.85) | |
Return On Equity | (1.75) | (1.66) |
The data published in BIO Key's official financial statements usually reflect BIO Key's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BIO Key International. For example, before you start analyzing numbers published by BIO accountants, it's critical to develop an understanding of what BIO Key's liquidity, profitability, and earnings quality are in the context of the Software space in which it operates.
Please note, the presentation of BIO Key's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BIO Key's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BIO Key's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BIO Key International. Please utilize our Beneish M Score to check the likelihood of BIO Key's management manipulating its earnings.
BIO Key Workforce Analysis
Traditionally, organizations such as BIO Key use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BIO Key within its industry.BIO Key Manpower Efficiency
Return on BIO Key Manpower
Revenue Per Employee | 178.4K | |
Revenue Per Executive | 455K | |
Net Loss Per Employee | 179.2K | |
Net Loss Per Executive | 456.9K | |
Working Capital Per Employee | 92.7K | |
Working Capital Per Executive | 236.3K |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is BIO Key's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.62) | Revenue Per Share 17.484 | Quarterly Revenue Growth 0.323 | Return On Assets (0.27) | Return On Equity (1.26) |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.